Skip to main content
Erschienen in: Journal of Bone and Mineral Metabolism 2/2009

01.03.2009 | Original Article

Nucleotide variations in genes encoding carbonic anhydrase 8 and 10 associated with femoral bone mineral density in Japanese female with osteoporosis

verfasst von: Seijiro Mori, Ikuyo Kou, Hidenori Sato, Mitsuru Emi, Hideki Ito, Takayuki Hosoi, Shiro Ikegawa

Erschienen in: Journal of Bone and Mineral Metabolism | Ausgabe 2/2009

Einloggen, um Zugang zu erhalten

Abstract

Osteoporosis is a multi-factorial common disease, which is caused by combination of genetic as well as environmental factors. Among several factors, osteoclast acidification pathways during bone resorption might play an important role. Carbonic anhydrases, consisting of a gene family, are essential for pH regulation by the osteoclast. Clinically, use of carbonic anhydrase inhibitors has been known to be associated with a bone-sparing effect as judged by spine bone mineral density (BMD). Here, we investigated single nucleotide polymorphisms (SNPs) in carbonic anhydrase genes that are expressed in bone tissues, i.e., CA8 and CA10, for possible association with femoral and lumbar BMD among 337 Japanese women with osteoporosis participated in BioBank Japan project. Significant correlation was observed between CA8 SNP, rs6984526, and femoral BMD (= 0.00029); homozygous carriers of the major (C) allele (n = 166) had the highest BMD (0.754 ± 0.006 g/cm2, mean ± SD), while heterozygous carriers (n = 135) were intermediate (0.741 ± 0.07 g/cm2) and homozygous T-allele carriers (n = 31) had the lowest BMD (0.691 ± 0.012 g/cm2). CA8 SNP as well displayed significant association with lumbar BMD in recessive model (= 0.00017). In addition, CA10 SNP, rs2106329, also displayed strong association with femoral BMD (= 0.00002). The results suggest that the variations of CA8 and CA10 loci may be important determinants of osteoporosis in Japanese women.
Literatur
1.
Zurück zum Zitat NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, Therapy (2001) JAMA 285:785–795CrossRef NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, Therapy (2001) JAMA 285:785–795CrossRef
2.
Zurück zum Zitat Orimo H, Hayashi Y, Fukunaga M, Sone T, Fujiwara M, Shiraki M, Kushida K, Miyamoto S, Soen S, Nishimura J, Oh-hashi Y, Hosoi T, Gorai I, Tanaka H, Igai T, Kishimoto H (2001) Diagnostic criteria for primary osteoporosis: year 2000 revision. J Bone Miner Metab 19:331–337PubMedCrossRef Orimo H, Hayashi Y, Fukunaga M, Sone T, Fujiwara M, Shiraki M, Kushida K, Miyamoto S, Soen S, Nishimura J, Oh-hashi Y, Hosoi T, Gorai I, Tanaka H, Igai T, Kishimoto H (2001) Diagnostic criteria for primary osteoporosis: year 2000 revision. J Bone Miner Metab 19:331–337PubMedCrossRef
3.
Zurück zum Zitat Peacock M, Turner CH, Econs MJ, Foroud T (2002) Genetics of osteoporosis. Endocr Rev 23:303–326PubMedCrossRef Peacock M, Turner CH, Econs MJ, Foroud T (2002) Genetics of osteoporosis. Endocr Rev 23:303–326PubMedCrossRef
4.
Zurück zum Zitat Albagha OM, Ralston SH (2003) Genetic determinants of susceptibility to osteoporosis. Endocrinol Metab Clin North Am 32:65–81PubMedCrossRef Albagha OM, Ralston SH (2003) Genetic determinants of susceptibility to osteoporosis. Endocrinol Metab Clin North Am 32:65–81PubMedCrossRef
5.
Zurück zum Zitat Liu YZ, Liu YJ, Robert RR, Deng HW (2003) Molecular studies of identification of genes for osteoporosis: the 2002 update. Endocrinology 177:147–196CrossRef Liu YZ, Liu YJ, Robert RR, Deng HW (2003) Molecular studies of identification of genes for osteoporosis: the 2002 update. Endocrinology 177:147–196CrossRef
6.
Zurück zum Zitat Kenny AD (1985) Role of carbonic anhydrase in bone: plasma acetazolamide concentrations associated with inhibition of bone loss. Pharmacology 31:97–107PubMedCrossRef Kenny AD (1985) Role of carbonic anhydrase in bone: plasma acetazolamide concentrations associated with inhibition of bone loss. Pharmacology 31:97–107PubMedCrossRef
7.
Zurück zum Zitat Pierce WM Jr, Nardin GF, Fuqua MF, Sabah-Maren E, Stern SH (1991) Effect of chronic carbonic anhydrase inhibitor therapy on bone mineral density in white women. J Bone Miner Res 6:347–354PubMedCrossRef Pierce WM Jr, Nardin GF, Fuqua MF, Sabah-Maren E, Stern SH (1991) Effect of chronic carbonic anhydrase inhibitor therapy on bone mineral density in white women. J Bone Miner Res 6:347–354PubMedCrossRef
8.
Zurück zum Zitat Tsukamoto K, Orimo H, Hosoi T, Miyao M, Yoshida H, Watanabe S, Suzuki T, Emi M (2000) Association of bone mineral density with polymorphism of the human matrix Gla protein locus in elderly women. J Bone Miner Metab 28:27–30CrossRef Tsukamoto K, Orimo H, Hosoi T, Miyao M, Yoshida H, Watanabe S, Suzuki T, Emi M (2000) Association of bone mineral density with polymorphism of the human matrix Gla protein locus in elderly women. J Bone Miner Metab 28:27–30CrossRef
9.
Zurück zum Zitat Mein CA, Barratt BJ, Dunn MG, Siegmund T, Smith AN, Esposito L, Nutland S, Stevens HE, Wilson AJ, Phillips MS, Jarvis N, Law S, de Arruda M, Todd JA (2000) Evaluation of single nucleotide polymorphism typing with invader on PCR amplicons and its automation. Genome Res 10:330–343PubMedCrossRef Mein CA, Barratt BJ, Dunn MG, Siegmund T, Smith AN, Esposito L, Nutland S, Stevens HE, Wilson AJ, Phillips MS, Jarvis N, Law S, de Arruda M, Todd JA (2000) Evaluation of single nucleotide polymorphism typing with invader on PCR amplicons and its automation. Genome Res 10:330–343PubMedCrossRef
10.
Zurück zum Zitat Ota N, Nakajima T, Nakazawa I, Suzuki T, Hosoi T, Orimo H, Inoue S, Shirai Y, Emi M (2001) A nucleotide variant in the promoter region of the interleukin-6 gene associated with decreased bone mineral density. J Hum Genet 46:267–272PubMedCrossRef Ota N, Nakajima T, Nakazawa I, Suzuki T, Hosoi T, Orimo H, Inoue S, Shirai Y, Emi M (2001) A nucleotide variant in the promoter region of the interleukin-6 gene associated with decreased bone mineral density. J Hum Genet 46:267–272PubMedCrossRef
11.
Zurück zum Zitat Breton S (2001) The cellular physiology of carbonic anhydrases. JOP 2:159–164PubMed Breton S (2001) The cellular physiology of carbonic anhydrases. JOP 2:159–164PubMed
12.
Zurück zum Zitat Rousselle AV, Heymann D (2002) Osteoclastic acidification pathways during bone resorption. Bone 30:533–540PubMedCrossRef Rousselle AV, Heymann D (2002) Osteoclastic acidification pathways during bone resorption. Bone 30:533–540PubMedCrossRef
13.
Zurück zum Zitat Taniuchi K, Nishimori I, Takeuchi T, Fujikawa-Adachi K, Ohtsuki Y, Onishi S (2002) Developmental expression of carbonic anhydrase-related proteins VIII, X, and XI in the human brain. Neuroscience 112:93–99PubMedCrossRef Taniuchi K, Nishimori I, Takeuchi T, Fujikawa-Adachi K, Ohtsuki Y, Onishi S (2002) Developmental expression of carbonic anhydrase-related proteins VIII, X, and XI in the human brain. Neuroscience 112:93–99PubMedCrossRef
Metadaten
Titel
Nucleotide variations in genes encoding carbonic anhydrase 8 and 10 associated with femoral bone mineral density in Japanese female with osteoporosis
verfasst von
Seijiro Mori
Ikuyo Kou
Hidenori Sato
Mitsuru Emi
Hideki Ito
Takayuki Hosoi
Shiro Ikegawa
Publikationsdatum
01.03.2009
Verlag
Springer Japan
Erschienen in
Journal of Bone and Mineral Metabolism / Ausgabe 2/2009
Print ISSN: 0914-8779
Elektronische ISSN: 1435-5604
DOI
https://doi.org/10.1007/s00774-008-0031-9

Weitere Artikel der Ausgabe 2/2009

Journal of Bone and Mineral Metabolism 2/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.